Skip to main content

There is no need to inform the IRB. However:

1) If your study is a greater-than-minimal risk study that involves some type of patient care, you must ensure your suspension does not increase any risk to those study subjects.

2) If possible, make sure you contact any study subject who will be affected by this suspension (i.e., a study visit will be cancelled, etc.)

3) You should make a note in your study records of this temporary suspension along with the justification and any actions taken in case you are ever audited.